CJC-1295 No DAC 5mg + Ipamorelin 5mg Research Blend

CJC-1295 No DAC 5mg + Ipamorelin 5mg Research Blend

CJC-1295 No DAC + Ipamorelin is a dual-pathway research peptide blend supplied by Unbothered Peptides strictly for laboratory and scientific research.

This blend pairs CJC-1295 No DAC, a short-acting GHRH analogue, with Ipamorelin, a selective ghrelin receptor agonist. Together, they are commonly studied in relation to growth hormone pulse signalling and downstream IGF-1 research pathways.

Research Background

The 1:1 format combines 5mg CJC-1295 No DAC with 5mg Ipamorelin, creating a 10mg research blend. This combination is widely discussed in peptide research because it activates two separate receptor pathways involved in growth hormone signalling.

Mechanism of Action

• CJC-1295 No DAC: Studied for its interaction with GHRH receptors and influence on growth hormone pulse amplitude. It is commonly described as a short-acting GHRH analogue.
• Ipamorelin: Studied for its interaction with the ghrelin receptor pathway and selective growth hormone release signalling.

When studied together, the two compounds are commonly researched for their combined effect on physiological growth hormone pulse models rather than sustained elevation.

Half-Life & Activity Window

• CJC-1295 No DAC: commonly reported around 30 minutes
• Ipamorelin: commonly reported around 2 hours

Although plasma half-lives are relatively short, downstream GH and IGF-1 signalling cascades may extend for several hours in research models.

Product Details

• Product: CJC-1295 No DAC + Ipamorelin
• Size: 10mg total blend
• Blend: 5mg CJC-1295 No DAC + 5mg Ipamorelin
• Format: Lyophilised research peptide blend
• Use: Research purposes only

Research use only. This product is not intended for human consumption, medical use, veterinary use, diagnosis, treatment, cure or prevention of any disease.